$VCYT
Veracyte Inc Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000138410119000046 Filed on April 30, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$30.14M	$29.53M	$20.04M
YoY Change	32.46%	47.34%	21.96%
Cost Of Revenue	$8.777M	$8.513M	$7.867M
YoY Change	6.44%	8.21%	24.93%
Gross Profit	$21.36M	$21.02M	$12.17M
YoY Change	47.25%	72.63%	20.12%
Gross Profit Margin	70.88%	71.17%	60.75%
Selling, General & Admin	$20.86M	$19.38M	$17.19M
YoY Change	34.12%	12.77%	28.69%
% of Gross Profit	97.68%	92.22%	141.18%
Research & Development	$3.330M	$3.435M	$3.675M
YoY Change	-27.62%	-6.53%	-8.81%
% of Gross Profit	15.59%	16.34%	30.19%
Depreciation & Amortization	$920.0K	$945.0K	$980.0K
YoY Change	-7.07%	-3.57%	8.65%
% of Gross Profit	4.31%	4.5%	8.05%
Operating Expenses	$24.19M	$22.82M	$20.86M
YoY Change	20.03%	9.37%	20.0%
Operating Profit	-$3.100M	-$2.067M	-$8.955M
YoY Change	-47.61%	-76.92%	19.13%
Interest Expense	$235.0K	$303.0K	$448.0K
YoY Change	-51.14%	-32.37%	-44.0%
% of Operating Profit
Other Income/Expense, Net	$841.0K	$453.0K	$226.0K
YoY Change	460.67%	100.44%	126.0%
Pretax Income	-$2.490M	-$1.920M	-$9.180M
YoY Change	-60.16%	-79.08%	11.68%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$2.494M	-$1.917M	-$9.180M
YoY Change	-60.1%	-79.12%	11.68%
Net Earnings / Revenue	-8.28%	-6.49%	-45.81%
Basic Earnings Per Share
Diluted Earnings Per Share	-$54.62K	-$46.64K	-$267.9K
COMMON SHARES
Basic Shares Outstanding	41.64M shares	41.11M shares	34.29M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$192.6M	$67.80M	$27.20M
YoY Change	709.24%	149.26%	-47.18%
Cash & Equivalents	$192.6M	$67.84M	$27.15M
Short-Term Investments
Other Short-Term Assets	$2.600M	$2.400M	$2.100M
YoY Change	44.44%	14.29%	-4.55%
Inventory	$5.104M	$3.768M	$4.557M
Prepaid Expenses
Receivables	$19.63M	$16.62M	$13.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$220.0M	$90.62M	$47.05M
YoY Change	428.28%	92.6%	-29.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.150M	$8.114M	$9.215M
YoY Change	-9.8%	-11.95%	-13.53%
Goodwill	$1.057M	$1.057M	$1.057M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.061M	$1.049M	$466.0K
YoY Change	77.42%	125.11%	266.93%
Total Long-Term Assets	$32.43M	$32.92M	$24.14M
YoY Change	36.1%	36.37%	-8.25%
TOTAL ASSETS
Total Short-Term Assets	$220.0M	$90.62M	$47.05M
Total Long-Term Assets	$32.43M	$32.92M	$24.14M
Total Assets	$252.4M	$123.5M	$71.19M
YoY Change	285.54%	73.53%	-23.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.061M	$4.064M	$3.356M
YoY Change	106.98%	21.1%	28.53%
Accrued Expenses	$9.820M	$8.788M	$8.483M
YoY Change	16.5%	3.6%	24.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$15.32M	$14.33M	$11.84M
YoY Change	47.44%	21.03%	25.8%
LONG-TERM LIABILITIES
Long-Term Debt	$585.0K	$12.85M	$25.02M
YoY Change	-97.67%	-48.62%	0.29%
Other Long-Term Liabilities	$12.20M	$12.60M	$4.100M
YoY Change	205.0%	207.32%	-6.82%
Total Long-Term Liabilities	$585.0K	$12.85M	$25.02M
YoY Change	-97.67%	-48.62%	0.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.32M	$14.33M	$11.84M
Total Long-Term Liabilities	$585.0K	$12.85M	$25.02M
Total Liabilities	$28.14M	$39.77M	$41.18M
YoY Change	-29.05%	-3.44%	4.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$238.5M	-$236.0M	-$220.3M
YoY Change	5.29%	7.15%	16.97%
Common Stock	$462.7M	$319.8M	$250.3M
YoY Change	83.39%	27.77%	3.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$224.2M	$83.77M	$30.01M
YoY Change
Total Liabilities & Shareholders Equity	$252.4M	$123.5M	$71.19M
YoY Change	285.54%	73.53%	-23.13%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$2.494M	-$1.917M	-$9.180M
YoY Change	-60.1%	-79.12%	11.68%
Depreciation, Depletion And Amortization	$920.0K	$945.0K	$980.0K
YoY Change	-7.07%	-3.57%	8.65%
Cash From Operating Activities	-$2.460M	-$1.011M	-$7.413M
YoY Change	-20.65%	-86.36%	-8.37%
INVESTING ACTIVITIES
Capital Expenditures	-$650.0K	$765.0K	$227.0K
YoY Change	22.64%	237.0%	-63.09%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$20.00K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$660.0K	-$749.0K	-$227.0K
YoY Change	24.53%	229.96%	26.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$137.8M		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net		$12.50M	$0.00
YoY Change
Cash From Financing Activities	127.9M	-$8.394M	$901.0K
YoY Change	53200.0%	-1031.63%	63.82%
NET CHANGE
Cash From Operating Activities	-2.460M	-$1.011M	-$7.413M
Cash From Investing Activities	-660.0K	-$749.0K	-$227.0K
Cash From Financing Activities	127.9M	-$8.394M	$901.0K
Net Change In Cash	124.8M	-$10.15M	-$6.739M
YoY Change	-3781.42%	50.68%	-12.71%
FREE CASH FLOW
Cash From Operating Activities	-$2.460M	-$1.011M	-$7.413M
Capital Expenditures	-$650.0K	$765.0K	$227.0K
Free Cash Flow	-$1.810M	-$1.776M	-$7.640M
YoY Change	-29.57%	-76.75%	-12.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41642603	shares
CY2019Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2516000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4064000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13168000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16615000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9186000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8788000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	313800000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	319733000	USD
CY2018Q1	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-30000	USD
CY2019Q1	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-556000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6209657	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6235250	shares
CY2018Q4	us-gaap	Assets Assets	120638000	USD
CY2019Q1	us-gaap	Assets Assets	123537000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	96952000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	90616000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77995000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67841000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34494000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27755000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78598000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68444000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6739000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10154000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8116335	shares
CY2019Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9104825	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40863202	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41509240	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40863202	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41509240	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9177000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1917000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	7867000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	8513000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	482000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3447000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-767000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	366000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	140000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-37000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	239000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	448000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	28996000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	31596000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3899000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	980000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	945000	USD
CY2018Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2019Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	16000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6412000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4951000	USD
CY2016Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1200000	USD
CY2018Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	233000	USD
CY2016Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	874000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	238000	USD
CY2018Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	71000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	75000	USD
CY2018Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	735000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11733000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5644000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6904000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	1057000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	1057000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-510000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1726000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	303000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	356000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	228000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3402000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	3768000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0753
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18260000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6841000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2543000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2472000	USD
CY2019Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	476000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2774000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3837000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1086000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1049000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	226000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	453000	USD
CY2018Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-93000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2401000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2332000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1671000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	40883000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	39765000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120638000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	123537000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13059000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14329000	USD
CY2018Q1	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	400000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1357000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23925000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12854000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	901000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8394000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-227000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-749000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7413000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1011000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9177000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1917000	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8955000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2067000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1244000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12582000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9630000	USD
CY2018Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3900000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	227000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	765000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	397000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	491000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	37225000	USD
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2387000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2392000	USD
CY2018Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	55000000	USD
CY2018Q1	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	403000	USD
CY2019Q1	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	569000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4181000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8940000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8114000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	12500000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3675000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3435000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-234086000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-236003000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20041000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29529000	USD
CY2018Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14118000	USD
CY2018Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.25
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11543000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12477000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1175000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1759000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6235258	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6733949	shares
CY2018Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5750000	shares
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	30008000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	79755000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	83772000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2800000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34271254	shares
CY2018Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	91000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41168593	shares
CY2019Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	141000	USD
CY2018Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	1083000	USD
CY2019Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	1598000	USD
CY2018Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Non Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee	1000	USD
CY2019Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Non Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee	20000	USD
CY2018Q1	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	56000	USD
CY2019Q1	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	95000	USD
CY2016Q4	vcyt	Finance Lease Upfront Payment FinanceLeaseUpfrontPayment	330000	USD
CY2018Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	228000	USD
CY2019Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	287000	USD
CY2018Q1	vcyt	Increase Decrease Operating Lease Right Of Use Asset Lease Liability IncreaseDecreaseOperatingLeaseRightOfUseAssetLeaseLiability	0	USD
CY2019Q1	vcyt	Increase Decrease Operating Lease Right Of Use Asset Lease Liability IncreaseDecreaseOperatingLeaseRightOfUseAssetLeaseLiability	80000	USD
CY2018Q1	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	70000	USD
CY2019Q1	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	64000	USD
CY2018Q1	vcyt	Legal Settlement Regarding Short Swing Profits Net Of Tax LegalSettlementRegardingShortSwingProfitsNetOfTax	310000	USD
CY2019Q1	vcyt	Number Of Major Financial Institutions With Which Cash And Cash Equivalents Deposited NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited	1	financial_institution
CY2019Q1	vcyt	Numberof Products NumberofProducts	3	product
CY2018Q1	vcyt	Sharebased Compensation Arrangementby Sharebased Payment Award Value Optionsand Non Option Equity Instruments Exercisesin Period SharebasedCompensationArrangementbySharebasedPaymentAwardValueOptionsandNonOptionEquityInstrumentsExercisesinPeriod	108000	USD
CY2019Q1	vcyt	Sharebased Compensation Arrangementby Sharebased Payment Award Value Optionsand Non Option Equity Instruments Exercisesin Period SharebasedCompensationArrangementbySharebasedPaymentAwardValueOptionsandNonOptionEquityInstrumentsExercisesinPeriod	4240000	USD
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; the useful lives of property and equipment; the recoverability of long-lived assets; the incremental borrowing rate for leases; the estimation of the fair value of intangible assets; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001384101-19-000046-index-headers.html	Edgar Link	pending
0001384101-19-000046-index.html	Edgar Link	pending
0001384101-19-000046.txt	Edgar Link	pending
0001384101-19-000046-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-03312019x10q.htm	Edgar Link	pending
vcyt-03312019xex101.htm	Edgar Link	pending
vcyt-03312019xex311.htm	Edgar Link	pending
vcyt-03312019xex312.htm	Edgar Link	pending
vcyt-03312019xex321.htm	Edgar Link	pending
vcyt-03312019xex322.htm	Edgar Link	pending
vcyt-20190331.xml	Edgar Link	completed
vcyt-20190331.xsd	Edgar Link	pending
vcyt-20190331_cal.xml	Edgar Link	unprocessable
vcyt-20190331_def.xml	Edgar Link	unprocessable
vcyt-20190331_lab.xml	Edgar Link	unprocessable
vcyt-20190331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
Veracyte Inc Stock $vcyt

2019 Q2 Form 10-Q Financial Statement

#000138410119000046 Filed on April 30, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT Veracyte Inc Stock $vcyt

2019 Q2 Form 10-Q Financial Statement

#000138410119000046 Filed on April 30, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
Veracyte Inc Stock $vcyt